A retrospective review of the frequency and nature of acute hypersensitivity reactions at a medium-sized infusion center: comparison to reported values and inconsistencies found in literature.

作者: Patricia A. DeMoor , Yuri Matusov , Colleen Kelly , Shobha Kolan , Linda Barnachea

DOI: 10.7150/JCA.2.153

关键词:

摘要: Purpose: To evaluate acute hypersensitivity reactions at the UCSD Moores Cancer Center in San Diego, compare our findings to those reported previously literature, and examine effectiveness of objective grading scale as represented by Common Terminology Criteria for Adverse Events (CTCAE). Patients Methods: Using available pharmacy electronic medical record data from 2006-2010, we examined (HSRs) using CTCAE v.3.0 v.4.0. A thorough literature review was also performed with reported. Results: We found 222 cases HSRs, which 50% were due immunotherapeutics. Most grade 1 or 2 any criteria. The clinical presentation HSRs varied between drug classes. different versions schema led inconsistencies ~50% all HSRs. Fifty-two percent not blood products rechallenged on same day. HSR frequencies each causative agent showed a striking variability, possibly indicating that previous studies used wide variety reporting systems adverse events. Conclusion: are common practice, most mild moderate. There studies. existence several subjective definitions could be contributing poor generalizability. Along an improved system minimize underreporting, standard objectively assessing is necessary purposes research practice.

参考文章(87)
Kristin M. Leiferman, Gerald J. Gleich, Anaphylaxis: implications of monoclonal antibody use in oncology. Oncology. ,vol. 23, pp. 7- 13 ,(2009)
Zhao, Guo, Baohua, Haiyan, A New Anticancer Drug 中国科学院院刊:英文版. pp. 73- 73 ,(2002)
Schilsky R, Reddick Rl, Reichert Cm, Von Hoff Dd, Muggia Fm, Rozencweig M, Young Rc, Toxic effects of cis-dichlorodiammineplatinum(II) in man. Cancer treatment reports. ,vol. 63, pp. 1527- 1531 ,(1979)
Amanullah Khan, Norwood Hill, William Grater, Ayten MacLellan, Ellen Loeb, Joseph M. Hill, Atopic Hypersensitivity to cis-Dichlorodiammineplatinum(II) and Other Platinum Complexes Cancer Research. ,vol. 35, pp. 2766- 2770 ,(1975)
Lars Meyer, Torsten Zuberbier, Margitta Worm, Helmut Oettle, Hanno Riess, Hypersensitivity Reactions to Oxaliplatin: Cross-Reactivity to Carboplatin and the Introduction of a Desensitization Schedule Journal of Clinical Oncology. ,vol. 20, pp. 1146- 1147 ,(2002) , 10.1200/JCO.2002.20.4.1146
Eric L. Sievers, Richard A. Larson, Edward A. Stadtmauer, Elihu Estey, Bob Löwenberg, Hervé Dombret, Chatchada Karanes, Matthias Theobald, John M. Bennett, Matthew L. Sherman, Mark S. Berger, Catharine B. Eten, Michael R. Loken, Jacques J.M. van Dongen, Irwin D. Bernstein, Frederick R. Appelbaum, , Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse Journal of Clinical Oncology. ,vol. 19, pp. 3244- 3254 ,(2001) , 10.1200/JCO.2001.19.13.3244
E A Eisenhauer, W W ten Bokkel Huinink, K D Swenerton, L Gianni, J Myles, M E van der Burg, I Kerr, J B Vermorken, K Buser, N Colombo, European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. Journal of Clinical Oncology. ,vol. 12, pp. 2654- 2666 ,(1994) , 10.1200/JCO.1994.12.12.2654
D M Peereboom, R C Donehower, E A Eisenhauer, W P McGuire, N Onetto, J L Hubbard, M Piccart, L Gianni, E K Rowinsky, Successful re-treatment with taxol after major hypersensitivity reactions. Journal of Clinical Oncology. ,vol. 11, pp. 885- 890 ,(1993) , 10.1200/JCO.1993.11.5.885
K. M. Zanotti, L. A. Rybicki, A. W. Kennedy, J. L. Belinson, K. D. Webster, B. Kulp, G. Peterson, M. Markman, Carboplatin Skin Testing: A Skin-Testing Protocol for Predicting Hypersensitivity to Carboplatin Chemotherapy Journal of Clinical Oncology. ,vol. 19, pp. 3126- 3129 ,(2001) , 10.1200/JCO.2001.19.12.3126
D. Schrijvers, J. Wanders, L. Dirix, A. Prove, I. Vonck, A. van Oosterom, S. Kaye, Coping with toxicities of docetaxel (TaxotereTM) Annals of Oncology. ,vol. 4, pp. 610- 611 ,(1993) , 10.1093/OXFORDJOURNALS.ANNONC.A058599